Trial Profile
Prospective, Multi-center, Randomized, Non-blind Trial to Assess the Efficacy and Safety of Moxifloxacin Versus Sulbactam/Ampicillin in the Treatment of Pulmonary Abscess and Aspiration Pneumonia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Jan 2010
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary) ; Ampicillin/sulbactam; Ampicillin/sulbactam
- Indications Aspiration pneumonia; Lung abscess
- Focus Adverse reactions
- Sponsors Bayer
- 17 Jan 2010 New trial record